Luca Fabris, MD, PhD

Department of Molecular Medicine (DMM), University of Padua, Padua, Italy

With a Medical degree at Padua University, Italy (1987), Luca Fabris got his PhD at University of Milan, Italy (1997), after a research program developed at University of Birmingham, UK (1995-96). In 2005, he was nominated assistant Professor at the University of Padua, School of Medicine. Currently, as associate Professor in Gastroenterology, he leads a laboratory of experimental Hepatology in the Department of Molecular Medicine, in the same University.

Over the last 20 years, he has focused his scientific interests on topics related to pathophysiology of cholangiopathies, both of inflammatory and neoplastic origin, mainly devoted to liver cell biology studies. From 2012, he has been holding an appointment as adjunct Professor in the Yale University, CT, USA, where he is involved in the program of genetic biliary diseases and cancers.

On the clinical side, he has developed a longstanding experience, mostly devoted to the clinical management of rare liver diseases, in particular primary cholangiopathies. From 2012 to 2016, Dr Fabris was a steering committee member of the International Primary Sclerosing Cholangitis (PSC) Study Group, and from 2016, chair of the working group of ‘Malignancies in PSC’. From 2016, Dr Fabris is a steering committee member of the AASLD Special Interest Group on Cholestatic and Autoimmune Liver Diseases.